Aspirin for Cholangiocarcinoma Prevention: New Targets to Shift the Dogma From Ascertained Risk to Possible Prevention
Hepatology - United States
doi 10.1002/hep.28999
Full Text
Open PDFAbstract
Available in full text
Date
February 3, 2017
Authors
Publisher
Wiley